Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 9,250 LYEL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 9,250 | n/a |
| Jun 10, 2026 | INCYTE CORP (INCY) | Grant/Award | 1,642 | n/a |
| Mar 23, 2026 | AGILENT TECHNOLOGIES, INC. (A) | Grant/Award | 2,158 | $241.2K |
| Mar 3, 2026 | PDS Biotechnology Corp (PDSB) | Grant/Award | 54,876 | n/a |
| Jun 12, 2025 | INCYTE CORP (INCY) | Grant/Award | 2,518 | n/a |
| Jun 11, 2025 | PDS Biotechnology Corp (PDSB) | Grant/Award | 22,700 | n/a |
| May 19, 2025 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 130,000 | n/a |
| Apr 2, 2025 | Lyell Immunopharma, Inc. (LYEL) | Purchase | 35,640 | $20.0K |
| Mar 18, 2025 | AGILENT TECHNOLOGIES, INC. (A) | Grant/Award | 1,819 | $220.4K |
| Jun 25, 2024 | PDS Biotechnology Corp (PDSB) | Grant/Award | 9,000 | n/a |